Ref ID: 18587
Author:
A. Khoder, M. Petrou, C. Thomas, R. Szydlo, E. Kanfer,
D. Marin, A. Rahemtulla, A. Luqmani, J. Hung, D. MacDonald,
D. Milojkovic, J. Apperley, K. Rezvani
Author address:
Imperial College NHS trust (London, UK
Full conference title:
Annual Meeting of the EBMT, 36th
Abstract:
Fungal infection is a major cause of mortality in stem cell
transplantation (SCT). We retrospectively analyzed all fungal
isolates from SCT patients referred to the mycology lab for susceptibility and speciation from 1997 to 2006. During this period
760 and 455 patients underwent autologous and allogeneic
SCT for haematological malignancies respectively. Positive
isolates were reported in 78 (10%) of recipients of autologous
SCT (30 MM, 27 NHL and 22 others) and in 79 (17%) of alloSCT patients. In the latter group (45 CML, 13 acute leukaemia
and MDS, 11 others), 18 received reduced-intensity-conditioned and 61 myeloblative allografts. The donor was matched
sibling (38), matched unrelated (36) and mismatched related or
unrelated (5). Two-thirds were T- depleted. Median CD34 + cell
dose was 4.3 x 10
6
/kg and median time to neutrophil engraftment (TNE) was 21 d. 52% & 47% of patients with positive
isolates had grade II-IV aGvHD and moderate-severe cGvHD
respectively. Risk factors for positive isolate were aGVHD
(P = 0.03), unrelated donor (UD) (P = 0.012) and T-depletion
(P = 0.001). No signifi cant association between TNE, CD34 +
dose or conditioning and occurrence of positive isolates was
seen. There were 494 positive isolates in 157 patients (407
yeasts and 87 fi lamentous fungi, FF). Non-albicans (NA) candida accounted for 57% of all yeasts (74% C. glabrata and C.
krusei). The most frequent species leading to candidaemia
were C. glabrata (26%), C. krusei (17%) and C. albicans (17%).
In vitro 64% of NA candida were resistant to fl uconazole (FCZ).
Most C. glabrata (88%) were resistant to itraconazole (ITZ) and
35% to voriconazole (VCZ). Conversely C. albicans was invariably sensitive to FCZ or other azoles. All yeasts were sensitive
to amphotericin B (AMB) and whilst caspofungin was active
against Candida its activity against other yeasts was variable.
FF were more common in alloSCT (4.6%) than ASCT (1.4%).
The most common FF were Aspergillus species (74%), Penicillium (6%) and Fusarium (5%). In vitro no FF were inhibited
by FCZ. Here, we show that T-depletion, an UD and GvHD
increase the risk of fungal infection. C. glabrata and C. krusei
are the predominant NA candida isolates and have a signifi cant
rate of azole resistance. A fumigatus is the predominant FF.
This study is limited by its retrospective nature. We are performing prospective studies to defi ne risk factors and analyze
the impact of changing anti-fungal prophylaxis and treatment
on transplant outcome.
Abstract Number: P772
Conference Year: 2010
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a